Quaker Chemical (KWR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on May 7, 2025, with shareholders voting on director elections, executive compensation, and auditor ratification.
Shareholders of record as of March 4, 2025, are eligible to vote, with 17,670,915 shares outstanding.
The Board recommends voting FOR all proposals, including the election of four directors, approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as auditor.
Forward-looking statements highlight risks such as customer demand, inflation, supply chain disruptions, geopolitical events, and cybersecurity.
Voting matters and shareholder proposals
Proposals include electing four directors, an advisory vote on executive compensation, and ratification of the independent auditor.
Shareholders may submit proposals for the 2026 meeting by December 1, 2025, and director nominations by February 6, 2026.
The Board recommends voting FOR all director nominees and proposals.
Board of directors and corporate governance
The Board is divided into three classes, with four Class III directors up for election to serve until 2028.
Board leadership is separated between a non-executive Chairman and CEO, with an independent Lead Director.
Ten of twelve directors are independent; diversity is emphasized, with 50% of the Board self-identifying as minorities or women.
Four standing committees: Audit, Compensation and Human Resources, Governance, and Sustainability, all with independent members.
Directors are subject to overboarding policies and annual self-evaluations.
Latest events from Quaker Chemical
- Q4 2025 delivered higher sales and EBITDA, led by Asia-Pacific growth and acquisitions.KWR
Q4 202524 Feb 2026 - Growth, margin recovery, and targeted M&A drive resilience in a fragmented global market.KWR
Gabelli Funds' 16th Annual Specialty Chemicals Symposium3 Feb 2026 - Net income and margins rose in Q2 2024 despite lower sales, with further growth expected.KWR
Q2 20242 Feb 2026 - Q3 2024 sales fell 6% as Americas and EMEA softened, but Asia/Pacific grew and margins held firm.KWR
Q3 202417 Jan 2026 - Q1 2025 sales and earnings declined, but liquidity and acquisitions support a stable outlook.KWR
Q1 202523 Dec 2025 - Q4 2024 saw lower sales and earnings, but cash flow and acquisitions support 2025 growth.KWR
Q4 202419 Dec 2025 - Q2 2025 saw 4% sales growth and Asia gains, but margins fell and a major impairment drove a net loss.KWR
Q2 20253 Nov 2025 - Q3 2025 sales rose 7% with strong Asia-Pacific growth and higher adjusted EBITDA and EPS.KWR
Q3 20252 Nov 2025